NRXBF: Tremendous Progress Made in Groundbreaking Treatment
NurExone (OTC-NRXBF) is a preclinical stage biotech company that is developing a breakthrough treatment for spinal cord injuries that has the...
174 Views
BLRX: Stem Cell Mobilization Presentation at ASH
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
165 Views
ORMP: Advancing Clinical Activities
ORMP is leveraging its strong balance sheet to invest in early stage companies, primarily focusing on the medical & biopharma space. ORMP has...
208 Views
Primer: Freightos (CRGO US) - Nov 2025
Freightos is a first-mover in the digitization of the global freight industry, operating a SaaS-enabled marketplace that connects carriers,...
207 Views
AI And Investing In The New Technological Revolution
​Understanding the phases of technological revolutions can guide investment strategies, with AI seen as a critical milestone in the current...
174 Views